Shock Wave Therapy for Lower Limb Lymphedema
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Lymphedema, Lower Limb
In brief
This is a double-blind randomized clinical trial to compare the effect of shock wave therapy on lower limb lymphedema. There are two arms: A) complex decongestive therapy + extracorporeal shock waves therapy; B) complex decongestive therapy plus placebo extracorporeal shock waves.
Key facts
- Study ID
- NCT06454734
- Run by
- Parc de Salut Mar
- People needed
- 30
- Starts
- 2024-05-28
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2025-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients with lower limb lymphedema
- Lymphedema of at least 6 months of evolution
- The lymphedema must affect at least the knee to the foot
- Moderate or severe lymphedema (grades 2 or 3)
- Sign the informed consent
You may not qualify if…
- Under 18 years of age
- Coagulation disorders (hemophilia, treatment with acenocoumarol, etc.)
- Current or previous deep vein thrombosis of the lower extremity
- Pregnancy
- Electronic implantable medical devices as pacemaker implants, medication pumps, etc
- Having received treatment with complex decongestive therapy or shock waves during the last 6 months
- Treatment with corticosteroids or radiotherapy in the area to be treated in the last 6 weeks
- Active oncological disease in the area to be treated
- Active infectious-inflammatory process in the area to be treated
- Cognitive or sensory deficits that prevent collaboration
- Inability to walk independently or inability to attend therapy
Where it is running
- Hospital del Mar — Barcelona, Spain (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.